Fairvoy Private Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.24M Buy
3,665
+270
+8% +$319K 0.85% 33
2026
Q2
$4.07M Buy
3,395
+128
+4% +$131K 0.82% 35
2026
Q1
$3M Sell
3,267
-6
-0.2% -$6.08K 0.72% 40
2025
Q4
$3.52M Sell
3,273
-6
-0.2% -$5.74K 0.79% 35
2025
Q3
$2.5M Sell
3,279
-537
-14% -$400K 0.57% 45
2025
Q2
$2.97M Buy
3,816
+50
+1% +$38.9K 0.74% 40
2025
Q1
$3.11M Buy
3,766
+9
+0.2% +$7.49K 0.85% 35
2024
Q4
$2.9M Buy
+3,757
New +$3.11M 0.77% 40

Other funds holding LLY

Fairvoy Private Wealth's LLY Position: Q3 2026 in Review

Fairvoy Private Wealth increased its Eli Lilly (LLY) stake by 8% in Q3 2026, buying an estimated $319K and bringing the position to 3,665 shares worth $4.24M. The position accounts for 0.85% of the portfolio, ranked #33.

Fairvoy Private Wealth first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. 1,509 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Fairvoy Private Wealth held 3,665 shares of Eli Lilly worth $4.24M as of Q3 2026.
  • Fairvoy Private Wealth bought 270 Eli Lilly shares in Q3 2026, an estimated $319K.
  • Eli Lilly made up 0.85% of Fairvoy Private Wealth's portfolio in Q3 2026, its #33 holding.
  • Fairvoy Private Wealth first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • 1,509 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Fairvoy Private Wealth's 13F filing for Q3 2026, filed 19 Oct 2026.